Literature DB >> 29220019

Amgen cholesterol antibody feud could kill key IP rule.

Mark Ratner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29220019     DOI: 10.1038/nbt1217-1118

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  New class PCSK9 blockers stride into cholesterol market.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2015-08       Impact factor: 54.908

2.  Citizen science lures gamers into Sweden's Human Protein Atlas.

Authors:  Mark Peplow
Journal:  Nat Biotechnol       Date:  2016-05-06       Impact factor: 54.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.